Literature DB >> 7906851

Co-expression of dopamine transporter mRNA and tyrosine hydroxylase mRNA in ventral mesencephalic neurones.

S J Augood1, K Westmore, P J McKenna, P C Emson.   

Abstract

Radioactive in situ hybridization was used to map the cellular localization of dopamine (DA) transporter mRNA-containing cells in the adult rat central nervous system. The distribution of DA transporter mRNA-containing cells was compared to adjacent sections processed to visualize tyrosine hydroxylase (TH) mRNA, a marker of catecholamine containing neurones. TH mRNA-containing cells, visualized using an alkaline phosphatase labelled probe, were detected in the hypothalamus, midbrain and pons; the strongest hybridization signals being detected in the substantia nigra, ventral tegmental area and locus coeruleus. The distribution of DA transporter mRNA-containing cells was more restricted; a strong signal being detected in the substantia nigra pars compacta and ventral tegmental area only. No hybridization signal was detected in the locus coeruleus. By simultaneously hybridizing mesencephalic tissue with both the alkaline phosphatase-labelled TH probe and the 35S-labelled DA transporter probe we were able to demonstrate that both DA transporter and TH mRNAs are expressed by the same cells in the substantia nigra and ventral tegmental area. The restricted anatomical localization of DA transporter mRNA-containing cells and the lack of expression in the locus coeruleus and other adrenergic and noradrenergic cell groups confirms the DA transporter as a presynaptic marker of DA containing nerve cells in the rat brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7906851     DOI: 10.1016/0169-328x(93)90059-x

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  9 in total

Review 1.  Cannabinoid modulation of the dopaminergic circuitry: implications for limbic and striatal output.

Authors:  Megan L Fitzgerald; Eli Shobin; Virginia M Pickel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-11       Impact factor: 5.067

2.  Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter.

Authors:  S R Sesack; V A Hawrylak; C Matus; M A Guido; A I Levey
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

3.  Histochemical Characterization of the Dorsal Raphe-Periaqueductal Grey Dopamine Transporter Neurons Projecting to the Extended Amygdala.

Authors:  Qin Zhao; Tetsufumi Ito; Chika Soko; Yoshie Hori; Takafumi Furuyama; Hiroyuki Hioki; Kohtarou Konno; Miwako Yamasaki; Masahiko Watanabe; Satoshi Ohtsuka; Munenori Ono; Nobuo Kato; Ryo Yamamoto
Journal:  eNeuro       Date:  2022-05-31

4.  Regional dopamine transporter gene expression in the substantia nigra from control and Parkinson's disease brains.

Authors:  T J Counihan; J B Penney
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

5.  Selective deletion of the leptin receptor in dopamine neurons produces anxiogenic-like behavior and increases dopaminergic activity in amygdala.

Authors:  J Liu; S M Perez; W Zhang; D J Lodge; X-Y Lu
Journal:  Mol Psychiatry       Date:  2011-04-12       Impact factor: 15.992

6.  Effects of Passage Number and Differentiation Protocol on the Generation of Dopaminergic Neurons from Rat Bone Marrow-Derived Mesenchymal Stem Cells.

Authors:  Gabrielle Shall; Megan Menosky; Sarah Decker; Priya Nethala; Ryan Welchko; Xavier Leveque; Ming Lu; Michael Sandstrom; Ute Hochgeschwender; Julien Rossignol; Gary Dunbar
Journal:  Int J Mol Sci       Date:  2018-03-02       Impact factor: 5.923

7.  Two eARCHT3.0 Lines for Optogenetic Silencing of Dopaminergic and Serotonergic Neurons.

Authors:  Alexandra Krol; Violeta G Lopez-Huerta; Taylor E C Corey; Karl Deisseroth; Jonathan T Ting; Guoping Feng
Journal:  Front Neural Circuits       Date:  2019-02-01       Impact factor: 3.492

8.  Altered baseline and amphetamine-mediated behavioral profiles in dopamine transporter Cre (DAT-Ires-Cre) mice compared to tyrosine hydroxylase Cre (TH-Cre) mice.

Authors:  Muhammad O Chohan; Sari Esses; Julia Haft; Susanne E Ahmari; Jeremy Veenstra-VanderWeele
Journal:  Psychopharmacology (Berl)       Date:  2020-08-10       Impact factor: 4.415

9.  Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease.

Authors:  Julian L Goggi; Lifeng Qiu; Mei Chih Liao; Shivashankar Khanapur; Lingfan Jiang; Ramasamy Boominathan; Siddesh V Hartimath; Peter Cheng; Fui Fong Yong; Vanessa Soh; Xiaozhou Deng; Youshan Melissa Lin; Anna Haslop; Peng Wen Tan; Xiaoxia Zeng; Jolene W L Lee; Zhiwei Zhang; Pragalath Sadasivam; Eng King Tan; Sajinder K Luthra; William D Shingleton; Steve K W Oh; Li Zeng; Edward G Robins
Journal:  Stem Cell Res Ther       Date:  2020-08-08       Impact factor: 6.832

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.